Item 8.01 Other Events.

On February 13, 2020, Pulse Biosciences, Inc. (the "Company") issued a press release announcing that on February 13, 2020, it had received a letter from the U.S. Food and Drug Administration with regard to the Company's 510(k) submission.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS





  (d) Exhibits.




Exhibit No.       Description

   99.1             Press Release issued by Pulse Biosciences, Inc., dated
                  February 13, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses